Abstract
Non-alcoholic steatohepatitis (NASH) is part of the spectrum of non-alcoholic fatty liver disease (NAFLD), which includes from simple steatosis and steatohepatitis, to the most severe cirrhosis and carcinoma, which develops in the absence of excessive alcohol intake. NAFLD is the most common liver disorder in affluent societies. There is no proven treatment for NAFLD/NASH. One of the most frequent adverse effects of statins is an increase in hepatic aminotransferases. Studies that evaluate if the benefits of statins overcome the risks in NASH are lacking. The present study was conceived to explore the effect of both atorvastatin and diet on regression of steatohepatitis, using a chicken experimental model induced by a hyperlipidemic diet (HD). Plasma lipid levels, liver enzymes and hepatic histopathology, as well as image analysis were performed to determine changes in liver lipid deposits and inflammatory infiltration. Features of steatosis, cell-ballooning, and inflammation were scored to obtain the NAFLD activity score (NAS). A severe level of steatosis was found in animals fed on HD. Atorvastatin treated groups showed smaller size of lipid deposits and a lower level of inflammation than non-treated groups. Atorvastatin ther...Continue Reading
References
Jan 1, 1990·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·R G ElkinL R Hagey
Jun 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G Lee
Mar 6, 1999·Experimental Animals·M OkazakiK Oguchi
Apr 19, 2002·The New England Journal of Medicine·Paul Angulo
May 23, 2002·Seminars in Liver Disease·Shivakumar Chitturi, Jacob George
Oct 10, 2002·Lipids·Gita CherianRob Bildfell
Oct 17, 2002·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·E García-FuentesE García-Peregrín
Jul 26, 2003·Lipids·Tetsu EgawaSaburo Onishi
Mar 3, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bartolo García-PérezMariano Valdés
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E KleinerUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Sep 6, 2005·Journal of Atherosclerosis and Thrombosis·Hidetoshi AmagasaKatsuji Oguchi
Jan 18, 2006·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Robert G ElkinWolfgang J Schneider
Oct 27, 2006·Histopathology·S G Hübscher
Apr 3, 2007·Journal of Hepatology·Mattias EkstedtStergios Kechagias
Jun 5, 2007·Clinics in Liver Disease·Roslyn M London, Jacob George
Dec 13, 2007·Molecular Pharmaceutics·Jacob George, Christopher Liddle
Jan 12, 2008·World Journal of Gastroenterology : WJG·R Scott RectorJamal A Ibdah
Apr 30, 2008·World Journal of Gastroenterology : WJG·Tim C M A SchreuderChris J J Mulder
Nov 11, 2008·Experimental Biology and Medicine·Ignacio AyalaMaria T Castells
Citations
Jan 29, 2011·Lipids in Health and Disease·Guiyuan JiZhuoqin Jiang
Mar 5, 2014·Journal of Medicinal Food·Makoto FujimotoCarlo Selmi
Dec 3, 2014·Life Sciences·Ho Sung LeeJi Hoon Jeong
Apr 14, 2015·Journal of Avian Medicine and Surgery·Hugues BeaufrèreThomas N Tully
Jun 18, 2014·Biochemical and Biophysical Research Communications·Qiuxian PengHongbing Cai
May 5, 2016·Poultry Science·J E DavisD B Hales
Nov 27, 2010·Lancet·Vasilios G AthyrosUNKNOWN GREACE Study Collaborative Group
Jul 10, 2019·Poultry Science·M M ZhaoT Y Geng
Oct 3, 2018·Journal of Medicinal Food·Yoon Hee ChungJi Hoon Jeong
Nov 29, 2011·International Journal of Experimental Pathology·Viviane Trak-SmayraBernard Fromenty
Dec 29, 2020·Poultry Science·Qiang WuHuaqiao Tang
May 30, 2021·Environmental Science and Pollution Research International·Samar Saber IbrahimMohamed Aboubakr
May 28, 2021·Frontiers in Nutrition·Md Raihan Uzzaman PrinceShaikh J Uddin
Dec 2, 2020·Ecotoxicology and Environmental Safety·Siyu LiZhigang Zhang